Hudson Bay Capital Management
NVO

Hudson Bay Capital Management’s Novo Nordisk NVO Stock Holding History

Hudson Bay Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-426,200
Closed -$23.6M – 1438
2025
Q3 		$23.6M Buy
+426,200
New +$24.9M 0.08% 200
2025
Q2 		– Sell
-250,000
Closed -$17.4M – 1577
2025
Q1 		$17.4M Sell
250,000
-300,000
-55% -$24.8M 0.05% 285
2024
Q4 		$47.3M Buy
+550,000
New +$59.5M 0.17% 140

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Hudson Bay Capital Management's NVO Position: Q1 2026 in Review

Hudson Bay Capital Management reduced its Novo Nordisk (NVO) stake by 76% in Q1 2026, selling an estimated $19.2M and leaving 125,038 shares worth $4.6M. The position accounts for 0.02% of the portfolio, ranked #536.

Hudson Bay Capital Management first reported a position in NVO in Q3 2022 and has held it in 9 quarters since. The position peaked at $55.2M in Q4 2024. 1,276 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Hudson Bay Capital Management held 125,038 shares of Novo Nordisk worth $4.6M as of Q1 2026.
  • Hudson Bay Capital Management sold 404,165 Novo Nordisk shares in Q1 2026, an estimated $19.2M.
  • Novo Nordisk made up 0.02% of Hudson Bay Capital Management's portfolio in Q1 2026, its #536 holding.
  • Hudson Bay Capital Management first reported a position in Novo Nordisk in Q3 2022 and has held it in 9 quarters since.
  • Hudson Bay Capital Management's Novo Nordisk position peaked at $55.2M in Q4 2024.
  • 1,276 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.